| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/22/2000 | WO2000008004A8 Particle-forming compositions containing fused pyrrolocarbazoles |
| 06/22/2000 | WO2000006759A3 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same |
| 06/22/2000 | WO2000004954A3 Novel urokinase inhibitors |
| 06/22/2000 | CA2727746A1 Quinolone vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | CA2393442A1 Exo-r-mecamylamine formulation and use in treatment |
| 06/22/2000 | CA2362423A1 47 human secreted proteins |
| 06/22/2000 | CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 06/22/2000 | CA2355870A1 Reagents and methods useful for detecting diseases of the breast |
| 06/22/2000 | CA2355714A1 7-aryl-6(z)heptatrienoic acid retinamides as apoptosis inducing compounds and their use as anti-cancer agents |
| 06/22/2000 | CA2355363A1 Prostacyclin-stimulating factor-2 |
| 06/22/2000 | CA2355287A1 Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs |
| 06/22/2000 | CA2355249A1 Protease inhibitors |
| 06/22/2000 | CA2355161A1 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 06/22/2000 | CA2355039A1 Pancreatic polypeptide zsig66 |
| 06/22/2000 | CA2354873A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2 |
| 06/22/2000 | CA2354456A1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/22/2000 | CA2354422A1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/22/2000 | CA2354402A1 4,5-pyrazinoxindoles as protein kinase inhibitors |
| 06/22/2000 | CA2354323A1 Homer a new target of treating psychiatric disorders |
| 06/22/2000 | CA2354156A1 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 06/22/2000 | CA2353997A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp |
| 06/22/2000 | CA2353924A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors |
| 06/22/2000 | CA2353897A1 1,4-benzodiazepinone derivatives and their use as integrin antagonists |
| 06/22/2000 | CA2353593A1 Method of administering a compound to multi-drug resistant cells |
| 06/22/2000 | CA2351726A1 Hcg therapy for the treatment of breast cancer |
| 06/22/2000 | CA2351464A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4 |
| 06/22/2000 | CA2349501A1 Quinolone vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | CA2347922A1 Vanadium compounds for treating cancer |
| 06/22/2000 | CA2347770A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/22/2000 | CA2345752A1 Tricyclic nitrogen heterocycles as pde iv inhibitors |
| 06/22/2000 | CA2293023A1 Process for producing ucn-01 |
| 06/21/2000 | EP1009860A1 Antisense oligonucleotide inhibition of ras |
| 06/21/2000 | EP1009824A1 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-kappaB ACTIVATION |
| 06/21/2000 | EP1009823A1 Human papilloma virus inhibition by antisense oligonucleotides |
| 06/21/2000 | EP1009821A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 06/21/2000 | EP1009811A2 New tissue-specific calpaines, their production and their use |
| 06/21/2000 | EP1009771A1 Peptides which elicit cytotoxic t cellular immunity |
| 06/21/2000 | EP1009767A1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 06/21/2000 | EP1009755A1 Steroid sulfatase inhibitors and methods for making and using the same |
| 06/21/2000 | EP1009753A1 Hypoxia-regulated genes |
| 06/21/2000 | EP1009747A1 Ureido and thioureido derivatives of 4-amino-2(5h)-furanones and 4-amino-2(5h)-thiophenones as antitumor agents |
| 06/21/2000 | EP1009743A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 06/21/2000 | EP1009739A2 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 06/21/2000 | EP1009738A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 06/21/2000 | EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 06/21/2000 | EP1009736A1 Malonic acid based matrix metalloproteinase inhibitors |
| 06/21/2000 | EP1009447A1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same |
| 06/21/2000 | EP1009442A1 Improvements in or relating to regulation of t cell activation |
| 06/21/2000 | EP1009439A1 Polymer-platinum compounds |
| 06/21/2000 | EP1009436A2 Acridine derivative for increasing the oral bioavailability of taxanes |
| 06/21/2000 | EP1009420A1 Conjugates useful in the treatment of prostate cancer |
| 06/21/2000 | EP1009418A1 Robinia pseudoacacia lectin and its uses |
| 06/21/2000 | EP1009402A4 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| 06/21/2000 | EP1009402A1 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| 06/21/2000 | EP1009401A1 Dithiolopyrrolones and their corresponding monoxides and dioxides as antineoplastic agents |
| 06/21/2000 | EP1009384A1 A method of administering liposomal encapsulated taxane |
| 06/21/2000 | EP1009381A1 Carotenoid microemulsions |
| 06/21/2000 | EP0825875B1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence |
| 06/21/2000 | DE19858779A1 New 3-acylamino-propionic acid and 3-sulfonylamino-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiovascular and renal disorders, migraine and cancer |
| 06/21/2000 | DE19858331A1 Tricyclische Stickstoffheterocyclen als PDE IV Inhibitoren Tricyclic nitrogen heterocycles as PDE IV inhibitors |
| 06/21/2000 | CN1257539A Short peptides which selectively modulate intracellular signalling |
| 06/21/2000 | CN1257538A Short peptides which selectively modulate the activity of serine/threonine kinases |
| 06/21/2000 | CN1257503A 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo (3,2-D] pyrimidine-4-ones |
| 06/21/2000 | CN1257501A Process for preparing 6-0-monoesters of castanospermine |
| 06/21/2000 | CN1257477A Metalloproteinase inhibitors |
| 06/21/2000 | CN1256924A Aikanghua powder for treating cancer |
| 06/21/2000 | CN1256916A 9-cis-retinonic acid and medicinal use of salt and ester thereof |
| 06/21/2000 | CN1053668C Novel compound, process for preparing same and antitumor agent |
| 06/21/2000 | CN1053662C New tricyclic amide compounds, processes for their preparation and the pharmaceutical compositions containing same |
| 06/21/2000 | CN1053658C Aminostilbazole derivative and medicine |
| 06/21/2000 | CN1053569C Injectable solution and process for preparing same |
| 06/20/2000 | US6077950 Adjusting efficiency of animals antibody response by administering animal a polypeptide to activate antibody response |
| 06/20/2000 | US6077871 Droloxifene pharmaceutical compositions |
| 06/20/2000 | US6077864 Cyclic sulfone derivatives |
| 06/20/2000 | US6077862 Virus and cancer treatments |
| 06/20/2000 | US6077850 Useful for treating cyclooxygenase-2 mediated disorders, such as inflammation and inflammation-related disorders |
| 06/20/2000 | US6077844 Pyrimidine derivatives and methods of making and using these derivatives |
| 06/20/2000 | US6077828 Method for the prevention and treatment of cachexia and anorexia |
| 06/20/2000 | US6077709 Nucleotide sequences that prevent the expression of a human polypeptide that prevent apoptosis in tumor cells; anticarcinogenic agents |
| 06/20/2000 | US6077706 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 06/20/2000 | US6077685 Tumor suppressor merlin and antibodies thereof |
| 06/20/2000 | US6077663 Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 06/20/2000 | US6077545 Photosensitive composition, acid generator and organosilicon compound |
| 06/20/2000 | US6077499 First conjugate of a tumor targeting moiety, a therapeutic agent, and first member of a binding pair; clearing agent; and second conjugate of the complementary binding member of the binding pair, and second therapeutic agent |
| 06/20/2000 | CA2039212C Antineoplastic compounds and methods of using same |
| 06/20/2000 | CA2001618C Gestodene-containing agent for transdermal administration |
| 06/20/2000 | CA1341029C Peptidase inhibitors |
| 06/15/2000 | WO2000034780A2 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3? |
| 06/15/2000 | WO2000034499A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells |
| 06/15/2000 | WO2000034496A2 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene |
| 06/15/2000 | WO2000034494A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 06/15/2000 | WO2000034485A2 Beta-1,3-galactosyltransferase homologs |
| 06/15/2000 | WO2000034477A2 Neuron-associated proteins |
| 06/15/2000 | WO2000034474A2 Growth factor homolog zvegf3 |
| 06/15/2000 | WO2000034471A1 Human neural system growing-associated genes and the proteins encoded by the genes |
| 06/15/2000 | WO2000034467A1 Cancer cell vaccine |
| 06/15/2000 | WO2000034447A2 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 06/15/2000 | WO2000034338A2 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 06/15/2000 | WO2000034330A1 Cark protein and nucleic acid molecules and uses therefor |
| 06/15/2000 | WO2000034308A2 Protein transduction system and methods of use thereof |